We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Alexander Camenzind

Gowling WLG


Results 1 to 5 of 9
Most popular |Most recent

Dazed and Confused: A Closer Look at the Amended Patented Medicines Regulations

Canada - August 15 2019 While Friday’s announcement of amendments to the Patented Medicines Regulations (the “PMR”) may not have introduced any surprises, it did highlight...

Cole Meagher.

PMPRB shakeup - United States and Switzerland no longer relevant countries

Canada - August 9 2019 The Federal Government has announced the long awaited changes to the Patented Medicines Regulations, which are set to come into force on July 1, 2020...

Cole Meagher.

Going Overboard on Overbreadth

Canada - May 28 2019 Under the doctrine of overbreadth (also referred to as “claims broader than the invention” and “covetous claiming”), a patent is invalid if its claims...

Alex Gloor.

There and Back Again - Protective Agreements in the Federal Court

Canada - March 21 2019 A recent decision of the Federal Court has once again shifted the approach a party must take to keep their documents and information confidential...

Ben Pearson.

Federal Court Recognizes Limits of Decisions under the Old PM(NOC) Regulations

Canada - November 2 2018 In a recent decision of the Federal Court, Amgen Inc v Pfizer Canada Inc, 2018 FC 1078, 2018 FC 1078, Prothonotary Milczynski dismissed Pfizer’s...